Published in Clin Psychopharmacol Neurosci on December 26, 2014
Investigation of Dysregulation of Several MicroRNAs in Peripheral Blood of Schizophrenia Patients. Clin Psychopharmacol Neurosci (2016) 0.77
Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables. Am J Geriatr Psychiatry (2016) 0.75
Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment. Clin Psychopharmacol Neurosci (2016) 0.75
Peripheral Signatures of Psychiatric Disorders: MicroRNAs. Clin Psychopharmacol Neurosci (2017) 0.75
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
Acute-phase proteins and other systemic responses to inflammation. N Engl J Med (1999) 18.25
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 16.69
Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry (2003) 9.05
Adipose tissue, inflammation, and cardiovascular disease. Circ Res (2005) 8.72
Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol (2005) 8.39
Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr (2006) 4.72
Interleukin-6 and chronic inflammation. Arthritis Res Ther (2006) 3.74
Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol (2000) 3.67
The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol (2004) 3.29
Obesity and infection. Lancet Infect Dis (2006) 2.94
The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev (2007) 2.93
Leptin in immunology. J Immunol (2005) 2.62
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract (2014) 2.55
Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med (2009) 2.17
Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J (2001) 2.12
Obesity and immune function relationships. Obes Rev (2001) 1.80
Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci (1992) 1.78
Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. Biol Psychiatry (2012) 1.74
Dose equivalence of the antipsychotic drugs. J Psychiatr Res (1974) 1.69
Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm (2013) 1.59
Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci (2009) 1.43
Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci (1997) 1.41
Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab (2004) 1.38
Genes, environment and schizophrenia. Br J Psychiatry Suppl (2001) 1.33
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res (1999) 1.33
Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology (2008) 1.26
Stress, food, and inflammation: psychoneuroimmunology and nutrition at the cutting edge. Psychosom Med (2010) 1.22
Schizophrenia: etiology and course. Annu Rev Psychol (2004) 1.21
Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. Psychiatry Clin Neurosci (2010) 1.21
Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol (2002) 1.18
Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res (1994) 1.09
Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review. Schizophr Bull (2007) 1.08
Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients. Neuropsychobiology (2009) 1.07
Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr (2011) 1.03
Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin. Schizophr Res (2008) 1.03
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. Eur Neuropsychopharmacol (2000) 0.98
Leptin as a proinflammatory cytokine. Contrib Nephrol (2006) 0.97
Putative neuroprotective agents in neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.96
Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrinology (2012) 0.95
Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand (1994) 0.93
Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration. Schizophr Res (1999) 0.92
In vivo immunomodulatory effects of clozapine in schizophrenia. Schizophr Res (1997) 0.91
Stress in schizophrenia: an integrative view. Eur J Pharmacol (2000) 0.90
Impact of adiposity on immunological parameters. Arq Bras Endocrinol Metabol (2009) 0.89
Transforming growth factor-beta enhances and pro-inflammatory cytokines inhibit ob gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun (1997) 0.89
The influence of leptin on the dopamine system and implications for ingestive behavior. Int J Obes (Lond) (2009) 0.87
Factor analysis of risk variables associated with low-grade inflammation. Atherosclerosis (2008) 0.85
Increased interleukin-6 level in Taiwanese schizophrenic patients. Chang Gung Med J (2011) 0.84
Inflammatory cytokine network in schizophrenia. World J Biol Psychiatry (2013) 0.84
Neuroprotective effects of leptin in the context of obesity and metabolic disorders. Neurobiol Dis (2014) 0.83
Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication. Neuropsychiatr Dis Treat (2005) 0.82
Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia. Psychiatry Clin Neurosci (2007) 0.81
[Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia]. Di Yi Jun Yi Da Xue Xue Bao (2004) 0.81
Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia. Psychiatr Danub (2013) 0.80
Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines. Int Immunopharmacol (2005) 0.80
Waist circumference is a potential indicator of metabolic syndrome in Singaporean Chinese. Ann Acad Med Singapore (2013) 0.76
Association between serum levels of bioavailable vitamin D and negative symptoms in first-episode psychosis. Psychiatry Res (2016) 0.75
Serum brain-derived neurotrophic factor (BDNF) and its association with remission status in Chinese patients with schizophrenia. Psychiatry Res (2014) 0.75